{"id":62821,"date":"2026-03-20T13:02:38","date_gmt":"2026-03-20T12:02:38","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/"},"modified":"2026-03-20T13:02:38","modified_gmt":"2026-03-20T12:02:38","slug":"qiagen-announces-form-20-f-annual-report-filing-for-2025-results","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/","title":{"rendered":"Qiagen Announces Form 20-F Annual Report Filing for 2025 Results"},"content":{"rendered":"
\n

VENLO, the Netherlands–(BUSINESS WIRE)–$QGEN<\/a> #QIAGEN<\/a>–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission. The document can be accessed on QIAGEN\u2019s website here<\/a>.<\/p>\n

<\/a>
<\/a><\/p>\n

\nQIAGEN will provide printed copies of the 2025 Annual Report to shareholders free of charge upon request. To obtain a printed copy of the 2025 Annual Report please use our contact form<\/a> or send an email to ir@qiagen.com<\/a>.<\/p>\n

\nAbout QIAGEN<\/b><\/p>\n

\nQIAGEN N.V., a Netherlands-based holding company, is a global leader in Sample to Insight solutions that enable customers to extract and analyze molecular information from biological samples containing the building blocks of life. Our Sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies prepare these biomolecules for analysis, while bioinformatics support the interpretation of complex data to deliver actionable insights. Automation solutions integrate these steps into streamlined, cost-effective workflows. QIAGEN serves more than 500,000 customers worldwide in the Life Sciences (academia, pharmaceutical R&D and industrial applications such as forensics) and molecular diagnostics (clinical healthcare). As of December 31, 2025, QIAGEN employed approximately 5,700 people across more than 35 locations. For more information, visit www.qiagen.com<\/a>.<\/p>\n

\nSource: QIAGEN N.V.<\/p>\n

\nCategory: Corporate<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations<\/b>
e-mail: ir@QIAGEN.com<\/a><\/p>\n

\nPublic Relations<\/b>
e-mail: pr@QIAGEN.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

VENLO, the Netherlands–(BUSINESS WIRE)–$QGEN #QIAGEN–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission. The document can be accessed on QIAGEN\u2019s website here. QIAGEN will … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62821","6":"format-standard","7":"category-industry"},"yoast_head":"\nQiagen Announces Form 20-F Annual Report Filing for 2025 Results - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Qiagen Announces Form 20-F Annual Report Filing for 2025 Results - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"VENLO, the Netherlands–(BUSINESS WIRE)–$QGEN #QIAGEN–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission. The document can be accessed on QIAGEN\u2019s website here. QIAGEN will ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-20T12:02:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260320968222\/en\/639304\/22\/QLogo_20mm_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Qiagen Announces Form 20-F Annual Report Filing for 2025 Results\",\"datePublished\":\"2026-03-20T12:02:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\\\/\"},\"wordCount\":247,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260320968222\\\/en\\\/639304\\\/22\\\/QLogo_20mm_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\\\/\",\"name\":\"Qiagen Announces Form 20-F Annual Report Filing for 2025 Results - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260320968222\\\/en\\\/639304\\\/22\\\/QLogo_20mm_RGB.jpg\",\"datePublished\":\"2026-03-20T12:02:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260320968222\\\/en\\\/639304\\\/22\\\/QLogo_20mm_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260320968222\\\/en\\\/639304\\\/22\\\/QLogo_20mm_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Qiagen Announces Form 20-F Annual Report Filing for 2025 Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Qiagen Announces Form 20-F Annual Report Filing for 2025 Results - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/","og_locale":"en_US","og_type":"article","og_title":"Qiagen Announces Form 20-F Annual Report Filing for 2025 Results - Pharma Trend","og_description":"VENLO, the Netherlands–(BUSINESS WIRE)–$QGEN #QIAGEN–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission. The document can be accessed on QIAGEN\u2019s website here. QIAGEN will ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/","og_site_name":"Pharma Trend","article_published_time":"2026-03-20T12:02:38+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260320968222\/en\/639304\/22\/QLogo_20mm_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Qiagen Announces Form 20-F Annual Report Filing for 2025 Results","datePublished":"2026-03-20T12:02:38+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/"},"wordCount":247,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260320968222\/en\/639304\/22\/QLogo_20mm_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/","url":"https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/","name":"Qiagen Announces Form 20-F Annual Report Filing for 2025 Results - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260320968222\/en\/639304\/22\/QLogo_20mm_RGB.jpg","datePublished":"2026-03-20T12:02:38+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260320968222\/en\/639304\/22\/QLogo_20mm_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260320968222\/en\/639304\/22\/QLogo_20mm_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/qiagen-announces-form-20-f-annual-report-filing-for-2025-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Qiagen Announces Form 20-F Annual Report Filing for 2025 Results"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62821","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62821"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62821\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62821"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62821"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62821"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}